![](/img/cover-not-exists.png)
Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study
Katlama, Christine, Assoumou, Lambert, Valantin, Marc-Antoine, Soulié, Cathia, Martinez, Esteban, Béniguel, Lydie, Bouchaud, Olivier, Raffi, François, Molina, Jean-Michel, Fellahi, Soraya, Peytavin, GLanguage:
english
Journal:
Journal of Antimicrobial Chemotherapy
DOI:
10.1093/jac/dkz224
Date:
July, 2019
File:
PDF, 301 KB
english, 2019